JAN 2009 – AstraZeneca joins Bio Nebraska

(January 29, 2009; Omaha, NE) Bio Nebraska Life Sciences Association welcomes AstraZeneca, a major international healthcare business engaged in research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services.

AstraZeneca is one of the world’s leading pharmaceutical companies with healthcare sales of $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.35 billion dollar healthcare business with 12,200 employees committed to improving people’s lives.

“We are happy to count AstraZeneca among our members,” says Amy Recker, executive director of Bio Nebraska Life Sciences Association. “They are leaders in the healthcare industry and demonstrate a true commitment to innovation.”


For more information about AstraZeneca, visit www.astrazeneca-us.com.